Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US11180780B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11180780-B2 |
| Application number | US-201715616841-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 7, 2017 |
| Priority date | Apr 30, 2009 |
| Publication date | Nov 23, 2021 |
| Grant date | Nov 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4-hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2-one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA-dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl-CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring microbial organism comprising a set of enzymes that convert 4-hydroxbutyryl-CoA to 1,3-butanediol (1,3-BDO), wherein said microbial organism comprises at least one heterologous nucleic acid encoding a crotonase that converts crotonoyl-CoA to 3-Hydroxybutyryl-CoA, and wherein the crotonase is expressed in a sufficient amount to produce 1,3-BDO. 2. The non-naturally occurring microbial organism of claim 1 , wherein said crotonase is encoded by one or more genes selected from the group consisting of crt, crt1, ech, paaA, paaB, phaA, phaB, maoC, paaF, paaG, abfD, Msed_1220, fadA, fadB, fadI, fadJ, and fadR, wherein each of said genes encode an enzyme capable of catalyzing hydration of crotonyl-CoA to form 3-hydroxybutyryl-CoA. 3. The non-naturally occurring microbial organism of claim 1 , further comprising at least one exogenous nucleic acid encoding: (a) a 3-hydroxybutyryl-CoA reductase (aldehyde forming) that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyraldehyde; or (b) a 3-hydroxybutyraldehyde reductase that converts 3-hydroxybutyraldehyde to 1,3-butanediol. 4. The non-naturally occurring microbial organism of claim 3 comprising at least one exogenous nucleic acid encoding the 3-hydroxybutyryl-CoA reductase (aldehyde forming) that converts 3-hydroxybutyryl-CoA to 3-hydroxybutyraldehyde and at least one exogenous nucleic acid encoding the 3-hydroxybutyraldehyde reductase that converts 3-hydroxybutyraldehyde to 1,3-butanediol. 5. The non-naturally occurring microbial organism of claim 3 , wherein said 3-hydroxybutyraldehdye reductase is encoded by one or more genes selected from the group consisting of alrA, ADH2, yqhD, bdh I, bdh II, adhA, 4hbd, adhI, P84067, mmsb, dhat, and 3hidh. 6. The non-naturally occurring microbial organism of claim 3 , wherein said 3-hydroxybutyryl-CoA reductase (aldehyde forming) is encoded by one or more genes selected from the group consisting of acr 1, sucD, bphG, bld, adhE, Msed_0709, mcr, asd-2, Sad 2370, Ald, and eutE. 7. The non-naturally occurring microbial organism of claim 1 , further comprising at least one exogenous nucleic acid encoding a 3-hydroxybutyryl-CoA reductase (alcohol forming) that converts 3-hydroxybutyryl-CoA to 1,3-butanediol. 8. The non-naturally occurring microbial organism of claim 7 , wherein said 3-hydroxybutyryl-CoA reductase (alcohol forming) is encoded by one or more genes selected from the group consisting of adhE, adhE2, mcr, Rcas_2929, NAP1_02720, MGP2080_00535, and FAR. 9. The non-naturally occurring microbial organism of claim 1 further comprising at least one exogenous nucleic acid encoding a 4-hydroxybutyryl-CoA dehydratase that converts 4-hydroxybutyryl-CoA to crotonyl-CoA. 10. The non-naturally occurring microbial organism of claim 9 , wherein said 4-hydroxybutyryl-CoA dehydratase is encoded by one or more genes selected from the group consisting of fumA, fumB, fumC, fumH, fum1, MmcB, MmcC, hmd, BACCAP_02294, ANACOL_02527, NtherDRAFT_2368, dmdA, dmdB, crt, crt1, ech paaA, paaB, phaA, phaB, maoC, paaF, paaG, abfD, Msed_1220, fadA, fadB, fadI, fadJ, and fadR. 11. The non-naturally occurring microbial organism of claim 1 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 12. The non-naturally occurring microbial organism of claim 1 , wherein said microbial organism is a bacterium. 13. The non-naturally occurring microbial organism of claim 12 , wherein said bacteria is E. coli. 14. A culture medium comprising the non-naturally occurring microbial organism of claim 1 . 15. The culture medium of claim 14 further comprising 1,3-BDO. 16. A method for producing 1,3-BDO, comprising culturing the non-naturally occurring microbial of claim 1 under conditions and for a sufficient period of time to produce 1,3-BDO. 17. The method of claim 16 further comprising separating 1,3-BDO from other components in the culture. 18. The method of claim 17 , wherein the separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography, or ultrafiltration. 19. The method of claim 17 , wherein the separating comprises distillation. 20. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism comprises three exogenous nucleic acids, each encoding an enzyme of the set. 21. The non-naturally occurring microbial organism of claim 1 , wherein at least one exogenous nucleic acid is a heterologous nucleic acid. 22. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism comprises four exogenous nucleic acids, each encoding an enzyme of the set.
transferring groups other than amino-acyl groups (2.3.1) · CPC title
Ammonia-lyases (4.3.1) · CPC title
transferring nitrogenous groups (2.6) · CPC title
with NAD+ or NADP+ as acceptor (1.1.1) · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.